German medicines watchdog rejects ‘new tenofovir’ pill
Once-daily raltegravir works as well as twice-daily for initial HIV treatment
Dolutegravir plus lamivudine dual therapy works well as initial HIV treatment
Long-acting injectable drugs work well for HIV maintenance therapy
HIV will only be cured with combinations too, conference delegates hear
New integrase inhibitor bictegravir looks promising in early studies
PRO 140 antibody injections maintain viral suppression in phase 2 study
